Several studies reported that inflammatory disorders, mediated by an elevated production of IL-1β and IL-18, play a critical role in the pathogenesis of CRC by re-shaping the immunological niche [123, 124]. The gene discussed is IL1B; the disease is colorectal carcinoma.